Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Confirmed: AFib ablation during CABG improves survival | Johnson & Johnson MedTech must now pay $442M | ASNC speaks to Congress
Monday, June 9, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

AFib ablation during CABG improves survival

Clinical guidelines already recommend that these procedures be performed together when applicable. However, researchers noted, it is still not terribly common among today’s surgeons. 

READ MORE >
CABG coronary artery bypass grafting heart surgery
Share on Twitter Share on Facebook Share on Linkedin

AFib ablation during CABG improves survival

Share on Twitter Share on Facebook Share on Linkedin
CABG coronary artery bypass grafting heart surgery
Clinical guidelines already recommend that these procedures be performed together when applicable. However, researchers noted, it is still not terribly common among today’s surgeons. 
READ MORE >

Judge triples damages in antitrust lawsuit, ordering Johnson & Johnson MedTech to pay $442M

A bad outcome for Johnson & Johnson MedTech just got worse. A jury previously ordered the company to pay $147M, but the new total is $442M.

READ MORE >
court judge gavel business man bankruptcy lawsuit
Share on Twitter Share on Facebook Share on Linkedin

Judge triples damages in antitrust lawsuit, ordering Johnson & Johnson MedTech to pay $442M

Share on Twitter Share on Facebook Share on Linkedin
court judge gavel business man bankruptcy lawsuit
A bad outcome for Johnson & Johnson MedTech just got worse. A jury previously ordered the company to pay $147M, but the new total is $442M.
READ MORE >

ASNC speaks to members of Congress about major trends in cardiology

The American Society of Nuclear Cardiology made its voice heard, pushing for legislation to repeal Medicare payment cuts and tie payments to inflationary increases. Prior authorization and a proposed tariff on radioisotopes were also discussed.

READ MORE >
Part of the ASNC delegation that visited with congressional members to to explain policy and payment challenges that face. Members of ASNC's Health Policy Committee from left: Daniel Huck, MD, MPH, David E. Winchester, MD, MS, FASNC, Suman Tandon, MD, FASNC, Vikas Veeranna, MD, Friederike Keating, MD, FASNC, and Attila Feher, MD, PhD.
Share on Twitter Share on Facebook Share on Linkedin

ASNC speaks to members of Congress about major trends in cardiology

Share on Twitter Share on Facebook Share on Linkedin
Part of the ASNC delegation that visited with congressional members to to explain policy and payment challenges that face. Members of ASNC's Health Policy Committee from left: Daniel Huck, MD, MPH, David E. Winchester, MD, MS, FASNC, Suman Tandon, MD, FASNC, Vikas Veeranna, MD, Friederike Keating, MD, FASNC, and Attila Feher, MD, PhD.
The American Society of Nuclear Cardiology made its voice heard, pushing for legislation to repeal Medicare payment cuts and tie payments to inflationary increases. Prior authorization and a proposed tariff on radioisotopes were also discussed.
READ MORE >

Featured Articles

‘A compelling alternative’: Polymer heart valve receives first commercial approval of its kind

A new surgical mitral valve from Foldax will now be commercially available in India. The valve is built using LifePolymer, a proprietary material that does not include animal tissue.

READ MORE >
Foldax Tria mitral valve
Share on Twitter Share on Facebook Share on Linkedin

‘A compelling alternative’: Polymer heart valve receives first commercial approval of its kind

Share on Twitter Share on Facebook Share on Linkedin
Foldax Tria mitral valve
A new surgical mitral valve from Foldax will now be commercially available in India. The valve is built using LifePolymer, a proprietary material that does not include animal tissue.
READ MORE >

Heart surgeons perform world’s first robotic TAVR explant and aortic valve replacement

The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve degeneration made a full replacement necessary. Surgeons ultimately removed the TAVR valve in addition to replacing her aortic and mitral valves—all with the help of advanced robotics.

READ MORE >
Vinay Badhwar, MD, and his team perform a robotic TAVR explant and aortic valve replacement. Image courtesy of WVU Medicine.
Share on Twitter Share on Facebook Share on Linkedin

Heart surgeons perform world’s first robotic TAVR explant and aortic valve replacement

Share on Twitter Share on Facebook Share on Linkedin
Vinay Badhwar, MD, and his team perform a robotic TAVR explant and aortic valve replacement. Image courtesy of WVU Medicine.
The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve degeneration made a full replacement necessary. Surgeons ultimately removed the TAVR valve in addition to replacing her aortic and mitral valves—all with the help of advanced robotics.
READ MORE >

A closer look at GE HealthCare's new affordable cardiac CT scanner

As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals. 

READ MORE >
Ty Bode, senior director of strategy at GE Healthcare, explains the details of a new, economical cardiac CT scanner GE Healthcare launched at the American College of Cardiology (ACC) 2025 meeting. The Revolution Vibe is designed specifically for coronary CT angiography (CCTA), but at a lower price point than the traditional high-end, flagship scanner that have traditional performed CCTA work.
Share on Twitter Share on Facebook Share on Linkedin

A closer look at GE HealthCare's new affordable cardiac CT scanner

Share on Twitter Share on Facebook Share on Linkedin
Ty Bode, senior director of strategy at GE Healthcare, explains the details of a new, economical cardiac CT scanner GE Healthcare launched at the American College of Cardiology (ACC) 2025 meeting. The Revolution Vibe is designed specifically for coronary CT angiography (CCTA), but at a lower price point than the traditional high-end, flagship scanner that have traditional performed CCTA work.
As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals. 
READ MORE >

TAVR specialists come together to explore new data, patient selection and much more

Care teams have a lot to consider when choosing the right treatment for patients with severe aortic stenosis. Two cardiologists and a veteran cardiothoracic surgeon are taking part in a new webinar focused on that very topic. 

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

TAVR specialists come together to explore new data, patient selection and much more

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Care teams have a lot to consider when choosing the right treatment for patients with severe aortic stenosis. Two cardiologists and a veteran cardiothoracic surgeon are taking part in a new webinar focused on that very topic. 
READ MORE >

In Case You Missed It

FDA wants new heart damage warnings added to COVID-19 vaccines

COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

READ MORE >
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology
Share on Twitter Share on Facebook Share on Linkedin

FDA wants new heart damage warnings added to COVID-19 vaccines

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology
COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.
READ MORE >

Cardiologist shares positive first-in-human data on TriCares TTVR device

The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.

READ MORE >
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist shares positive first-in-human data on TriCares TTVR device

Share on Twitter Share on Facebook Share on Linkedin
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.
READ MORE >

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.

READ MORE >
cardiologists heart doctors
Share on Twitter Share on Facebook Share on Linkedin

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Share on Twitter Share on Facebook Share on Linkedin
cardiologists heart doctors
Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.
READ MORE >

In Other News

AI newswatch: Nurses want in, transcriptionists on the way out, blockchain going up, more

If doctors are the heart of the hospital, nurses are surely the soul. And if that’s so, today’s AI has to be something like a nutritional supplement for the brains of the operation.

READ MORE >
AI artificial intelligence in healthcare
Share on Twitter Share on Facebook Share on Linkedin

AI newswatch: Nurses want in, transcriptionists on the way out, blockchain going up, more

Share on Twitter Share on Facebook Share on Linkedin
AI artificial intelligence in healthcare
If doctors are the heart of the hospital, nurses are surely the soul. And if that’s so, today’s AI has to be something like a nutritional supplement for the brains of the operation.
READ MORE >

Critical recall: Medtronic tracheostomy tube

The FDA is alerting healthcare providers about a problematic tracheostomy tube that has potential for causing serious or life-threatening injury. 

READ MORE >
medtronic tracheostomy recall
Share on Twitter Share on Facebook Share on Linkedin

Critical recall: Medtronic tracheostomy tube

Share on Twitter Share on Facebook Share on Linkedin
medtronic tracheostomy recall
The FDA is alerting healthcare providers about a problematic tracheostomy tube that has potential for causing serious or life-threatening injury. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease
Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup